Heart, Lung, Blood and Sleep Disorders
Last data update: Jun 22, 2024 . (Total: 47575 Documents since 2020)
Records 1-14 (of 14 Records) |
Query Trace: Heart Transplant[original query] |
---|
Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients. Peled Yael, et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2024 0 0. ![]() ![]() ![]() |
BNT162b2-vaccine-induced neutralization responses are immune correlates of clinical protection against SARS-CoV-2 in heart transplant recipients. Peled Yael, et al. Clinical transplantation 2023 0 0. e15091 ![]() ![]() ![]() |
Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients. Hazan Fanny, et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2023 0 0. ![]() ![]() |
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis. Lai Francisco Tsz Tsun et al. Journal of the American College of Cardiology 2022 12 (24) 2255-2265 ![]() ![]() ![]()
A total of 866 patients were included for analysis. Over the follow-up period, 1 death (1.0%) of 104 patients with postvaccination myocarditis and 84 deaths (11.0%) of 762 patients with viral infection–related myocarditis were identified. This study found a significantly lower rate of mortality among individuals with myocarditis after mRNA vaccination compared with those with viral infection–related myocarditis. Prognosis of this iatrogenic condition may be less severe than naturally acquired viral infection–related myocarditis.
|
Fourth BNT162b2 vaccination neutralization of omicron infection after heart transplantation. Peled Yael, et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2022 0 0. ![]() ![]() ![]() ![]() ![]() |
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variant. Peled Yael, et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2022 0 0. ![]() ![]() |
Sparing the Prod: Providing an alternative to endomyocardial biopsies with non-invasive surveillance after heart transplantation during COVID-19. Amadio Jennifer M, et al. CJC open 2022 0 0. ![]() ![]() |
COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy. Gill Jasmeet, et al. Journal of nephrology 2021 0 0. |
SARS-CoV-2 Infection and Emery-Dreifuss Syndrome in a Young Patient with a Family History of Dilated Cardiomyopathy. Dumitru Irina Magdalena, et al. Genes 2021 0 0. (7) ![]() |
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients. Kamar Nassim et al. The New England journal of medicine 2021 6 ![]()
Here, we report the humoral response in a group of 101 consecutive solid-organ transplant recipients (mean [±SD] age, 58±2 years; 69% were men) who were given three doses of the messenger RNA vaccine BNT162b2 (Pfizer–BioNTech). The group included 78 kidney-transplant recipients, 12 liver-transplant recipients, 8 lung-transplant or heart-transplant recipients, and 3 pancreas-transplant recipients. The first two doses were given 1 month apart, and the third dose was administered 61±1 days after the second dose.
|
Trends in post-heart transplant biopsies for graft rejection versus nonrejection. Jamil Aayla K, et al. Proceedings (Baylor University. Medical Center) 2021 0 0. (3) 345-348 ![]() |
Donor-derived cell-free DNA in a heart transplant patient with COVID-19. Sperry Brett W, et al. Clinical transplantation 2020 0 0. (11) e14070 |
Epidemiologic and clinical characteristics of heart transplant recipients during the 2019 coronavirus outbreak in Wuhan, China: A descriptive survey report. Ren Zong-Li, et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2020 0 0. (5) 412-417 ![]() |
Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients. Peled Yael, et al. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 0 0 0. ![]() ![]() ![]() |
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 21, 2024
- Content source: